Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model-Reference-Cited by-同舟云学术

Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model

Published:2018-11-05 Issue:2 Volume:74 Page:246-260
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Kratzer Bernhard¹^ORCID,Köhler Cordula¹,Hofer Sandra¹,Smole Ursula¹^ORCID,Trapin Doris¹,Iturri Jagoba²,Pum Dietmar²,Kienzl Philip³,Elbe-Bürger Adelheid³^ORCID,Gattinger Pia⁴,Mittermann Irene⁴^ORCID,Linhart Birgit⁴,Gadermaier Gabriele⁵^ORCID,Jahn-Schmid Beatrice⁴^ORCID,Neunkirchner Alina¹,Valenta Rudolf⁴^ORCID,Pickl Winfried F.¹^ORCID

Affiliation:

1. Institute of Immunology; Center for Pathophysiology, Infectiology and Immunology; Medical University of Vienna; Vienna Austria

2. Department of Nanobiotechnology; Institute for Biophysics; University of Natural Resources and Life Sciences Vienna; Vienna Austria

3. Department of Dermatology; Division of Immunology, Allergy and Infectious Diseases; Medical University of Vienna; Vienna Austria

4. Department of Pathophysiology and Allergy Research; Center for Pathophysiology, Infectiology and Immunology; Medical University of Vienna; Vienna Austria

5. Division of Allergy and Immunology; Department of Biosciences; University of Salzburg; Salzburg Austria

Funder

Austrian Science Foundation

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13573/fullpdf

Reference69 articles.

1. Pharmacological targeting of allergen-specific T lymphocytes;Tauber;Immunol Lett,2017

2. Dupilumab in persistent asthma;Wenzel;N Engl J Med,2013